Abstract:Objective To evaluate the expressions of estrogen receptor (ER) α and β in human prostate cancer and adjacent non-cancerous tissues,and to evaluate the correlation between the expression and the clinicopathological features and prognosis.Methods Immunohistochemical staining was used to detect ERα and ERβ in 85 prostate adenocarcinoma tissues,adjacent non-cancerous tissues,and 29 benign prostatic hyperplasia (BPH) tissues.The correlation between the expression and the clinicopathological features was analyzed by Spearman's coefficient.Cox's proportional hazards regression model was used to identify the risk factors for biological recurrence.Results There were significant differences between the expression of ERα in prostate cancer,adjacent non-cancerous tissues,and BPH [epithelial cell 0 (0/85),11.8％ (10/85) and 24.1％ (7/29),P=0.000; and in stromal cell 52.9％ (45/85),67.1％ (57/85),31.0％ (9/29),P =0.003].There were significant differences between the expression of ERβ in these groups [epithelial cell 36.5％ (31/85),61.2％ (52/85),100.0％ (29/29),P =0.000; and in stromal cell 49.4％ (42/85),72.9％ (62/85),79.3％ (23/29),P =0.001].The ERα expression in cancerous stromal cells was positively correlated with the PSA level (r =0.296,P =0.006) and Gleason score (r =0.404,P =0.000).The ERβ expression was negatively correlated with Gleason score in cancerous epithelial cells (r =-0.254,P =0.019) and stromal cells (r =-0.315,P =0.003).Multivariate analysis revealed that negative expression was an independent poor prognostic factor for the biological recurrence free survival after radical prostatectomy (HR =0.107,95.0％ CI 0.019-0.592,P =0.010).Conclusions There were significant differences between the expression of ERα and ERβ in prostate cancer,adjacent non-cancerous tissues,and BPH.ERα in cancerous stromal cells,ERβ in cancerous epithelial and stromal cells were related to the differentiation of prostate adenocarcinoma.ERβ in cancerous epithelial cells can be used as an independent prognostic factor for biological recurrence after radical surgery.

The Expression of Estrogen Receptor Α, Β in Different Breast Tissues and Its Relation with Breast Cancer

The expressing signification of estrogen receptorβ in breast cancer

Expression of Androgen Receptor in Breast Cancer and Its Prognostic Significance

Expression and Significance of Estrogen Receptor Isoforms in Different Breast Tissues

Prognostic Role of Estrogen Receptor Α and Estrogen Receptor Β in Gastric Cancer

Expression of Estrogen Receptor,progesterone Recptor and C-Erbb-2 in Breast Cancer Tissues

Expression of Erа and Erβ in normal human mammary gland and significance

[Expression and Significance of Estrogen Receptor Isoforms in the Development of Human Breast Carcinoma].

The expressions of C - erbB - 2, ER , PR in breast cancer and prognostic significance

Distribution and Prognostic Significance of Estrogen Receptors Expression in Prostate Cancer

Association of ERβ Expression with the Clinical Pathologic Indexes and Prognostic Biomarkers of Breast Cancer

[Expression of estrogen receptor, progesterone receptor, and human epithelial growth factor receptor 2 in breast cancer and the significance thereof: analysis of 910 cases].

Quantitative analysis of estrogen receptor subtypes in primary breast cancer

Expressions of Progesterone Receptor a and B in Breast Invasive Ductal Carcinoma and Their Clinical Significance

Expressions of estrogen receptor-related receptor alpha and estrogen receptors in endometrial carcinoma

Expression and Significance of Estrogen Receptor Α and Β in Prostate Cancer and Peri-Cancer Tissue

The Expression of ERβ Protein Correlates with Vascular Endothelial Growth Factor and Its Prognostic Significance in Human Breast Cancer

Estrogen Receptor Β and Estrogen Receptor Α36 Predict Differential Outcome of Patients with Breast Cancer

Expression of Aromatase Cytochrome P450 and Estrogen Receptor Β in Cervical Carcinoma Tissues and Its Clinical Significance

Expressions of c-erbB-2, ER, PR and their prognostic correlation in premenopausal and postmenopausal patients with breast cancer.

Expression of Estrogen Receptor Beta in Gastric Adenocarcinoma